Welcome to light therapy Guide
Fda Approved Light Therapy Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
Blue Light Therapy--a Form of Living Energy
from:The use of color therapy, such as the Blue Light Therapy, has been around a very long time, beginning with the healing temples of the ancient Greeks and Egyptians. Additionally, the ancient Chinese and Indians also used color in their healing practices that to this day are considered a major part of their alternative medicine practices, with the Blue Light Therapy part of the many colors used in the different healing methods.
Color therapy is based on how a person's organs are in relation to their chakras and meridians, resonating within individual frequencies. Blue Light Therapy is based on the color blue, a gentle color that is associated with communication, personal expression, and a person's ability to make correct decisions. By exposing the body to the blue color frequency, bringing about a more balanced state, the application of the Blue Light Therapy will increase a person's confidence when speaking, more of a mental relaxation, and increase a person's clarity in regard to their communication levels.
Studies on Blue Light Therapy have demonstrated that basically the use of light therapy resets the "biological clock" of the human body, with doses of 30 minutes to two hours each morning in front of a high-intensity fluorescent lamp an adequate time frame. One of the most highly successful treatments involve seasonal affective disorder (SAD), a condition where a person becomes depressed during shorter days during the fall and winter because of the reduced sunlight exposures that affect the body's internal clock.
In 2006, the Blue Light Therapy studies proved to be about 60% successful in the treatment of SAD. They showed that the body's biological clock responded in the most successful ways to a narrow band of wavelengths that were positioned in a range of 466 to 477 (nm). This color range was the blue of a clear blue sky. In another study, applying exposure to blue-LED light to Alzheimer's patients helped their body clocks adequately to sleep longer at night and also better than before the Blue Light Therapy treatment was given. But using the red light therapy in a similar Alzheimer study provided no successful results. And by applying yellow light therapy in combination with Blue Light Therapy, the Blue Light Therapy was cancelled out entirely.
The response to any form of light therapy usually will show results in about two to four days, but extensive disorders such as SAD or other forms of depression may take up to three weeks. If side effects occur, listed next, then decrease the time spent under the light:
• Eyestrain
• Visual disturbances
• Headaches
• Agitation
• Feelings of "weirdness"
• Sweating
• Nausea
Additionally, those individuals who have conditions such as sensitive skin or sensitive eyes need to discuss any form of light therapy with their therapist or doctor who are associated with the diagnosis and treatment before it is applied. If other forms of alternative medicine are used in conjunction with the light therapy, the therapist or doctor should also be notified.
Fda Approved Light Therapy News
FDA Approves Picato® (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 ...
PARSIPPANY, N.J., Jan. 25, 2012 /PRNewswire/ -- LEO Pharma announced today that the U.S. Food and Drug Administration (FDA) approved Picato® (ingenol mebutate) gel (0.015%, 0.05%) for the topical treatment ...
Read more...FDA Approves Subcutaneous Administration of VELCADE® In All Approved Indications
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration ha
Read more...Takeda receives FDA approval for VELCADE sNDA to treat MM
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma ...
Read more...Takeda launches EDARBYCLOR in the U.S. for treatment of hypertension
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced EDARBYCLOR (azilsartan medoxomil and chlorthalidone) is now available by prescription in U.S. pharmacies for the treatment of hypertension to lower blood pressure in adults.
Read more...FDA Approves Drug For Common Skin Cancer
On Monday, the US Food and Drug Administration approved a new type of drug to treat adult patients with advanced basal-cell carcinoma, the most common type of skin cancer. The drug's generic name is vismodegib and was developed by the US part of Roche Holding AG. It will be sold in the US by Roche's South San Francisco-based Genentech under the brand name Erivedge. Basal cell carcinoma is a slow ...
Read more...